Methicillin-resistance Staphylococcus Aureus
MRSA isolates become susceptible to antimicrobial of minor use
Published in TB and Outbreaks Week, February 15th, 2005
According to recent research from France, "The objective of our study was to investigate the relationship between molecular epidemiology and antibiotic susceptibility of MRSA during a 4-year period.
"In this aim, we determined the antibiotype of all MRSA identified during a yearly period of 3 months and typed 50 consecutive non-replicate MRSA isolates of each year. We also recorded antibiotic use."
"Susceptibility rates to gentamicin, tobramycin and ofloxacin remained stable, respectively, 95, 16 and 4%. In contrast," X....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Clostridium Perfringens
Clostridium perfringens can adapt to low temperatures - Epidemiology
Branching model estimates spread of infectious diseases in varying environments - Mycobacterium Bovis
Outbreak of M. bovis outbreak occurred in conditioned macaque colony - West Nile Virus
West Nile Virus IgM antibodies persist in CSF from patients with CNS disease - Antimicrobial Resistance
Antimicrobial use in equine hospitals lead to multidrug-resistant Salmonella - Avian Influenza
Bird flu battle could be a long one, top Vietnamese health official - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
